Key facts
- This page summarizes Elvia Cowan's Form 4 filing for Vaxcyte, Inc. (PCVX).
- 1 reported transaction and 0 derivative rows are listed below.
- Accepted by SEC: 09 Sep 2026, 17:52.
Elvia Cowan - 08 Sep 2026 Form 4 Insider Report for Vaxcyte, Inc. (PCVX)
- Reporting relationship
- SVP, Finance & CAO
- Issuer ticker
- PCVX
- Reported as of
- 08 Sep 2026
- Net transaction value
- $0
- SEC form
- 4
- Accepted by SEC
- 09 Sep 2026, 17:52:14 UTC
- Prior SEC filing
- 02 Sep 2026
- Source filing
- View source filing
- Reporting owner signature
- Elvia Cowan, by /s/ Peter N. Efremenko, Attorney-In-Fact
Source evidence
Original filing metadata and source links for verification.
4 source fields
Reporting owner
1 detail
Key filing fact
Elvia Cowan filed Form 4 for Vaxcyte, Inc. (PCVX) on 09 Sep 2026.
Change
- Previous filing in this sequence was filed on 02 Sep 2026.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reporting Owners (1)
CIK 0001960048
Primary reporting owner
Cowan Elvia
- Relationship
- SVP, Finance & CAO
- Address
- C/O VAXCYTE, INC., 825 INDUSTRIAL ROAD, SUITE 300, SAN CARLOS
- Signature
- Elvia Cowan, by /s/ Peter N. Efremenko, Attorney-In-Fact
- Signature date
- 09 Sep 2026
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
PCVX
transaction
Common Stock
Tax liability
- Transaction value
- Shares
- -1,327
- Change %
- -4.5%
- Price
- $60.36*
- Shares after
- 27,860
- Date
- 08 Sep 2026
- Ownership
- Direct
- Footnotes
- F1
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 1 footnote
Footnote F1
Represents shares surrendered to the Issuer to cover applicable tax withholding obligations realized upon the vesting of RSUs.